SANTAMARIA, ANGELO
 Distribuzione geografica
Continente #
EU - Europa 1.080
NA - Nord America 699
AS - Asia 155
OC - Oceania 5
SA - Sud America 3
AF - Africa 1
Totale 1.943
Nazione #
US - Stati Uniti d'America 697
IT - Italia 323
PL - Polonia 221
IE - Irlanda 208
SE - Svezia 180
CN - Cina 142
DE - Germania 27
FI - Finlandia 25
FR - Francia 23
UA - Ucraina 20
BE - Belgio 18
GB - Regno Unito 18
IN - India 9
NL - Olanda 7
AU - Australia 4
AT - Austria 3
EC - Ecuador 3
CA - Canada 2
CH - Svizzera 2
RO - Romania 2
RU - Federazione Russa 2
VN - Vietnam 2
AL - Albania 1
KR - Corea 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
TR - Turchia 1
Totale 1.943
Città #
Warsaw 220
Dublin 208
Chandler 141
Nyköping 100
Messina 85
Beijing 57
Ann Arbor 53
Jacksonville 53
Ashburn 41
Cambridge 30
Dearborn 30
Princeton 29
Medford 26
Des Moines 22
Brussels 16
Catania 16
Jinan 16
Shenyang 13
Woodbridge 13
Wilmington 12
Boardman 10
Tianjin 10
Rome 8
Seattle 8
Milan 7
Ningbo 7
Bremen 6
Pune 6
San Mateo 6
Washington 6
Bari 5
Hebei 5
Houston 5
Nanjing 5
Cagliari 4
Haikou 4
New York 4
Taizhou 4
Trecastagni 4
Viagrande 4
Bologna 3
Capoterra 3
Hangzhou 3
Hefei 3
Lanzhou 3
London 3
Mascalucia 3
Modling 3
Quito 3
Scandicci 3
Aci Sant'antonio 2
Acireale 2
Ascoli Piceno 2
Auburn Hills 2
Caltagirone 2
Dong Ket 2
Greifswald 2
Lancaster 2
Margherita di Savoia 2
Nanchang 2
Ottawa 2
Parma 2
Pomezia 2
Ravenna 2
Riva 2
Taiyuan 2
Vittoria 2
Waanrode 2
Zhengzhou 2
Akron 1
Anconetta 1
Argelato 1
Augusta 1
Baricella 1
Belgirate 1
Binasco 1
Brasov 1
Brisbane 1
Brutten 1
Carini 1
Casalnuovo Di Napoli 1
Casette 1
Castrofilippo 1
Chennai 1
Corigliano Calabro 1
Crotone 1
Dolo 1
Dumfries 1
Dundee 1
Frontone 1
Fucecchio 1
Fuzhou 1
Garbagnate Milanese 1
Gurgaon 1
Helsinki 1
Jiaxing 1
Los Angeles 1
Lucca 1
Mantova 1
Mapello 1
Totale 1.398
Nome #
Myo-Inositolo: protocollo non farmacologico per la prevenzione del Diabete Gestazionale - Outcomes clinici e metabolici 255
Inositolo e sindrome metabolica in menopausa 191
Metabolic effects of breastfeeding in women with previous gestational diabetes diagnosed according to the IADPSG criteria 110
Myo-inositol Supplementation for Prevention of Gestational Diabetes in Obese Pregnant Women: A Randomized Controlled Trial 102
Italian risk factor-based screening for gestational diabetes. 91
ADAM 12 and PAPP-A at 14–17 weeks' gestation as biomarkers of pre-eclampsia. 83
The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. 76
Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. 74
Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial 74
Perinatal outcome in a Caucasian population with gestational diabetes and preexisting diabetes first diagnosed in pregnancy 73
First trimester serum PAPP-A and NGAL in the prediction of late-onset pre-eclampsia. 70
Vigilance on use of drugs, herbal products, and food supplements during pregnancy: focus on fosfomycin 69
Decreased endothelial progenitor cells (EPCs) and increased Natural Killer (NK) cells in peripheral blood as possible early markers of preeclampsia: a case-control analysis 68
Coffee intake during pregnancy and neonatal low birth weight: data from a multicenter Italian cross sectional study 68
Myo-inositol and melatonin in the menopausal transition 62
Cadmium delays puberty onset and testis growth in adolescents 60
Peripheral blood CD34+ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis 58
Clinical and metabolic outcomes in pregnant women at risk for gestational diabetes mellitus supplemented with myo-inositol: a secondary analysis from 3 RCTs 54
Prenatally identified Pallister-Killian syndrome: Ultrasound pattern and diagnostic considerations 53
Maternal serum PAPP-A as an early marker of obstetric complications? 47
First trimester serum PAPP-A and NGAL in the prediction of late-onset preeclampsia 45
Second trimester amniotic fluid myo-inositol concentrations in women later developing gestational diabetes mellitus or pregnancy-induced hypertension 45
One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome 43
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial 43
Myo-inositol in Down syndrome amniotic fluid. A case-control study. 40
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e’ un marker di danno endoteliale? 33
Interleukin 31 is involved in intrahepatic cholestasis of pregnancy 25
null 24
Neutrophil Gelatinase-Associated Lipocalin (NGAL) e preeclampsia. 23
Totale 2.059
Categoria #
all - tutte 5.997
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.997


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201920 0 0 0 0 0 0 0 0 0 5 8 7
2019/2020309 16 15 13 9 7 50 27 26 16 59 50 21
2020/2021334 20 14 65 13 29 16 33 37 44 44 12 7
2021/2022250 5 34 5 11 6 1 12 9 11 67 28 61
2022/2023597 43 78 27 32 46 52 7 24 261 1 23 3
2023/2024121 16 16 6 22 12 24 0 20 0 5 0 0
Totale 2.059